AUTHORS' REPLY,-We agree that there is no evidence from randomised studies that screening and potentially curative treatment reduce the overall mortality from carcinoma of the prostate and we agree that length and lead time biases must be considered in judging screening programmes. Contrary to other studies, our population of 1494 men was randomly selected from a total population of 9026, so that the remaining 8432 who were not examined served as a control group. The follow up time, however, is still too short to enable any conclusions to be drawn.
Concerning the screening method and role of transrectal ultrasound screening, we found that the positive predictive value of digital rectal examination when performed by a urologist was 0-35, which is similar to the best results of transrectal ultrasound scanning reported.
Staging lymphadenectomy was done in all patients who received potentially curative treatment (10 had radical prostatectomy and one had radiotherapy). One SIR,-The recent paper by Dr Knud V Pedersen and colleagues described the assessment of cost and feasibility of screening for prostatic carcinoma, but their method of screening and their biopsy technique are baffling. ' The authors do not say whether the cytologist who took biopsies ofapparently abnormal prostates was aware of the clinical findings-this seems improbable because he took three fine needle aspirates from.each lobe. If the cytologist was unaware of the site of the nodular areas several of the cancers might have been missed by not biopsying the nodular areas directly. This may explain the relatively low finding of a 30% (13/44) incidence of carcinoma when previous studies have shown an incidence of 50-75% of carcinoma in prostatic nodules.' It is not stated which of the six biopsies taken in each patient were positive in the patients with carcinoma. Given these circumstances, I do not think that the technique is truly a screening test when such a potential for false negative results exists and the conclusions are thus flawed.
Random biopsying of the prostate gland under other circumstances is known to have a low yield.' It is not surprising to find a 30% incidence of carcinoma in what is, after all, a highly selected group (men with nodular prostates on rectal examination). From necropsies and simple prostatectomy specimens figures of 5-40% have been suggested.4
Finally, it is gratifying that there was a 100% response to the questionnaire sent to the men by the authors (though 331 did decline rectal examination for various reasons). This is unique in my experience and very impressive. anaesthesia with the option of having surgery for the other leg three months later. Patients are given a single dose of subcutaneous heparin 5000 units with premedication and on discharge are given elastic stockings to wear for three weeks. In our district there will always be another patient with a more pressing claim to an overnight stay in a surgical bed. A realistic appraisal of waiting time for routine surgery on varicose veins would have to be that it is infinite.
To date all my patients have accepted this policy without rancour. In over 300 cases over the past five years only one patient has had a pulmonary embolus. This patient was admitted to a private hospital, where he was given subcutaneous heparin 5000 units two hours preoperatively and twice a day for two days postoperatively and elastic stockings. Despite these measures the patient developed severe pleuritic chest pain after three weeks while on holiday abroad. On returning home he was admitted to hospital and given heparin, and a ventilation-perfusion scan confirmed the diagnosis of pulmonary embolus. The patient made a satisfactory recovery on anticoagulants.
A long term study is now needed to determine whether bilateral surgery is more dangerous than unilateral surgery, and another to show whether the addition of stripping the long saphenous vein from groin to knee, which sometimes precludes day case treatment, is of benefit. Proliferative retinopathy with growth hormone deficiency and diabetes mellitus SIR,-Dr C H Thivolet and colleagues report an unusual case of proliferative retinopathy in a woman with growth hormone deficiency and insulin dependent diabetes mellitus.' Both hypertension and renal impairment are known to exacerbate pre-existing diabetic retinopathy but measurements of the patient's blood pressure and renal function are not described.
Insulin like growth factor I is suggested to be a local mediator of diabetic retinopathy. But the authors do not take into account that only a small free fraction of the factor is present in the circulation and that most is bound to carrier proteins. When variations in glycaemic control, duration of diabetes, and renal function are controlled for the total concentrations of circulating insulin like growth factor I are relatively low in patients with advanced retinopathy. AUTHOR'S REPLY,-The suggested relation between blood pressure and renal impairment and proliferative retinopathy in our patient was unlikely to be important because proteinuria and hypertension occurred later. Total concentrations of circulating insulin like growth factor I in proliferative retinopathy may be either increased or normal in adult patients. The study by Arner et al, showing low insulin like growth factor I concentrations, is unique and should be reproduced by others. We agree that the complex of 40 kd and insulin like growth factor I may be particularly important and we will measure
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